What is KAPA's dilution risk score?

KAPA has a latest available DilutionScore record of 57/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for KAPA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for KAPA?

DilutionWatch tracks 25 SEC filing types for KAPA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect KAPA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For KAPA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for KAPA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for KAPA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

KAPA Dilution Risk Score: 57/100 (HIGH)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

65

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

35

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 45%

🔄 Reverse Split model est. 65%

• 50-day avg $0.57 below $1 exchange minimum

• 9 months cash with weak price

💰 Capital Raise model 33%

• Under 12 months cash (9mo)

• Active ATM program with $15M remaining capacity

🔁 Convertible Conversion model 15%

• Convertible debt present: 5.8% potential dilution

🔔 Track KAPA — Get forecast alerts →

Market Data

Market Cap$10.91M

Shares Outstanding23.70M

Float12.42M

Cash$2.63M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↓ 5.3% shares (2026Q1 vs prior)

11 institutional holders · 832.9K shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 463.8K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 111.3K shares

#3 VANGUARD FIDUCIARY TRUST CO 63.9K shares

+ 8 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest517.8K

Days to Cover1.0

% of Float4.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31

xbrl XBRL WARRANT 2024-12-31

424B3 ATM 2026-04-01

8-K 8K EVENT 2026-03-02

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual KAPA Dilution Snapshot

Kairos Pharma, Ltd. (KAPA) has a DilutionScore of 57/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $15.0M.
Recent SEC activity tracked for KAPA: 424B3 on 2026-04-01; 424B3 on 2026-04-01; 8-K on 2026-03-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.